News Briefs SpecificiT wins seed funding from AmorChem, Sanderling, Accel-Rx Kirk Falconer - 11 September 2017 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in